Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingNot stated2026-09-15NCT05712473

2 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Adult & Pediatric UrologyOmahaUnited States6
Arkansas UrologyLittle RockUnited States27
Comprehensive UrologyRoyal OakUnited States1
Comprehensive Urology Medical GroupLos AngelesUnited States3
Keystone Urology SpecialistsLancasterUnited States11
Pasadena Urological Medical GroupPasadenaUnited States2
Potomac UrologyAlexandriaUnited States4
Urology Associates NashvilleNashvilleUnited States1
Urology Associates of Central CaliforniaFresnoUnited States6
Urology Centers of AlabamaHomewoodUnited States14
Urology of St. LouisSt LouisUnited States3
Urology of VirginiaVirginia BeachUnited States14